TocILizumab in aorTitis in GCA (TILT)
TocILizumab in aorTitis in GCA (TILT)
Recruiting · NCT06271018 · Registry updated 2024-12-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TocILizumab in aorTitis in GCA (TILT) | Skin and Connective Tissue Diseases, aortic disorder, aortitis, arteritis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, immune system disorder, nervous system disorder, skin disorder, skin vascular disease, temporal arteritis, vascular disorder, vasculitis | Recruiting | Not stated | 2024-12-20 | NCT06271018 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Groupe français d'étude des Maladies Inflammatoires de loeil | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Département de Medecine interne et d'immunologie clinique - hôpital La Pitié Salpetrière | Paris | France | 1 |